
CRISPR Therapeutics AG CRSP
$ 58.17
-0.03%
Quarterly report 2025-Q3
added 11-10-2025
CRISPR Therapeutics AG Cash Conversion Cycle 2011-2026 | CRSP
Annual Cash Conversion Cycle CRISPR Therapeutics AG
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 K | - | - | 0.09 | 61.7 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 K | 0.09 | 387 |
Quarterly Cash Conversion Cycle CRISPR Therapeutics AG
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 55.8 | 60.4 | 21.7 | - | 16.7 | 0.02 | 24.9 | 35.5 | 88.8 | 299 | 70.6 | 0.12 | 0.04 | 28.4 | 26 | 69.8 | 14.3 | 7.38 | 91.2 | 7.41 | 100 | 66.9 | 97.6 | 123 | 186 | 362 | 335 | 125 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 362 | 0.02 | 85.7 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
209 | $ 11.68 | 21.41 % | $ 755 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
CASI Pharmaceuticals
CASI
|
11.9 | $ 0.83 | -2.51 % | $ 113 M | ||
|
Aclaris Therapeutics
ACRS
|
-881 | $ 2.68 | 0.94 % | $ 207 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
-186 | $ 37.22 | 4.17 % | $ 3.84 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
54.2 | $ 22.74 | 0.71 % | $ 2.69 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
CorMedix
CRMD
|
-215 K | $ 11.22 | -0.36 % | $ 571 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 27.37 | -0.92 % | $ 1.33 B | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
391 | $ 10.96 | -0.99 % | $ 722 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Axon Enterprise
AXON
|
86.2 | $ 620.25 | -1.02 % | $ 47 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.84 | 4.41 % | $ 17.8 M | ||
|
AstraZeneca PLC
AZN
|
-58 | $ 94.86 | -0.11 % | $ 96.9 B | ||
|
Cellectis S.A.
CLLS
|
-839 | $ 4.55 | 3.06 % | $ 116 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
bluebird bio
BLUE
|
-54.4 | - | - | $ 546 M | ||
|
Biogen
BIIB
|
387 | $ 184.12 | 0.83 % | $ 26.8 B |